Corneal Biomechanics and Continuous IOP Monitoring Using Soft Contact Lenses in Glaucomatous Patients (BIOLENS)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University Hospital, Bordeaux
ClinicalTrials.gov Identifier:
NCT01849536
First received: April 26, 2013
Last updated: November 21, 2013
Last verified: November 2013

April 26, 2013
November 21, 2013
January 2013
October 2013   (final data collection date for primary outcome measure)
Corneal biomechanics influence on IOP fluctuation. [ Time Frame: 24h ] [ Designated as safety issue: No ]
To evaluate corneal biomechanics influence on IOP fluctuation using SENSIMED Triggerfish® for glaucoma patients with a progressive visual field.
Same as current
Complete list of historical versions of study NCT01849536 on ClinicalTrials.gov Archive Site
  • Correlation between visual field defects and IOP fluctuations measurements. [ Time Frame: 24h ] [ Designated as safety issue: No ]
    To evaluate the correlation between visual field defects and IOP fluctuations measurements.
  • Correlation between the severity of optic nerve head damages and IOP. fluctuations measurements [ Time Frame: 24h ] [ Designated as safety issue: No ]
    To evaluate the correlation between the severity of optic nerve head damages measured with OCT and IOP fluctuations measurements.
  • Lens tolerance and corneal parameters after 24-hours of contact lens wear. [ Time Frame: 24h ] [ Designated as safety issue: Yes ]
    To evaluate lens tolerance and corneal parameters after 24-hours of contact lens wear (Pachymetry, Corneal hysteresis and Keratometry ).
Same as current
Not Provided
Not Provided
 
Corneal Biomechanics and Continuous IOP Monitoring Using Soft Contact Lenses in Glaucomatous Patients
Corneal Biomechanics and Continuous IOP Monitoring Using Soft Contact Lenses in Glaucomatous Patients

Ocular hypertension and its fluctuations is a major risk factor of glaucoma onset and progression. In normal eyes, IOP presents a circadian rhythm, but in glaucomatous eyes IOP circadian rhythm is altered and varied widely between patients. To date, the only way to evaluate 24 hour IOP fluctuations is a regular GAT-IOP measurement during a 24-hour hospitalization. This method is expensive and does not reflect physiological conditions because it requires IOP measurements during sleeping periods that may potentially produce artifacts.

Sensimed AG has developed a new medical device SENSIMED Triggerfish® that enables a 24-hour continuous monitoring of IOP fluctuations. As any IOP measurements methods, this medical device might be influenced by corneal properties of the cornea as central corneal thickness, keratometry or biomechanics. We, therefore, investigate the corneal lens tolerance, potential modifications of corneal parameters after a 24-hour wear of the lens, and its influence on data collected during the whole period of analysis. Then we will also analyze the influence of corneal parameters on continuous IOP fluctuations measured with the contact sensor and finally the correlation between data collected and the rate of progression (severity) of glaucoma evaluated with visual field test or optic nerve head damages.

Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Open Angle Glaucoma With a Progressive Visual Field
Device: SENSIMED Triggerfish®
Experimental: SENSIMED Triggerfish®
SENSIMED Triggerfish®
Intervention: Device: SENSIMED Triggerfish®
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
30
October 2013
October 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • At least 40 year-old
  • Signed informed consent
  • Visual field defect : at least 2 visual field already done, only the second one is considered for the visual field defect diagnosis, using theses criterion:

    • 3 adjacent points with at least 5db loss
    • Or 1 point with at least 10 db loss
    • Or a 10db difference between two adjacent points on either sides of the nasal horizontal meridian
  • Open angle glaucoma patients with a progressive visual field
  • For women of childbearing potential, adequate contraception

Exclusion Criteria:

  • Corneal dystrophy, scars or corneal surgery
  • Iridocorneal angle opening less than 3 using Shaeffer classification
  • History of glaucoma surgery
  • Any contraindications with the SENSIMED Triggerfish® device, as written in the user manual (active eye disease, severe dry eye, contraindications for silicone contact lens wear…)
  • Diabetes
  • Sleep Apnea Syndromes
  • Cataract surgery
  • High myopia
  • Pregnancy and lactation
  • Patients not able to understand the character and individual consequences of the investigation
Both
40 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT01849536
CHUBX 2012/20
Yes
University Hospital, Bordeaux
University Hospital, Bordeaux
Not Provided
Principal Investigator: Cédric SCHWEITZER, MD University Hospital Bordeaux, France
University Hospital, Bordeaux
November 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP